Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 3479
Gene Symbol: IGF1
IGF1
0.100 AlteredExpression disease BEFREE Serum IGF-1 levels (mean ± standard error) were not significantly different among the patients with different neurodegenerative diseases: Parkinson's disease (PD; n = 73), 112.1 ± 5.1 ng/mL; progressive supranuclear palsy (n = 15), 102.9 ± 8.3 ng/mL; multiple system atrophy (n = 22), 103.1 ± 37.6 ng/mL; Alzheimer's disease (AD; n = 18), 102.2 ± 9.4 ng/mL; amyotrophic lateral sclerosis (n = 6), 105.5 ± 27.4 ng/mL; dementia with Lewy bodies (n = 14), 82.4 ± 7.4 ng/mL; frontotemporal dementia (n = 6), 90.0 ± 17.0 ng/mL; and corticobasal syndrome (n = 2), 118.0 ± 14.0 ng/mL. 30903695 2019
Entrez Id: 3479
Gene Symbol: IGF1
IGF1
0.100 Biomarker disease BEFREE Effect of Vasicinone against Paraquat-Induced MAPK/p53-Mediated Apoptosis via the IGF-1R/PI3K/AKT Pathway in a Parkinson's Disease-Associated SH-SY5Y Cell Model. 31331066 2019
Entrez Id: 3479
Gene Symbol: IGF1
IGF1
0.100 Biomarker disease BEFREE Insulin-like growth factor-1 (IGF-1) function is impaired in Parkinson disease. 29865234 2018
Entrez Id: 3479
Gene Symbol: IGF1
IGF1
0.100 Biomarker disease BEFREE GSK3β, a downstream substrate of PI3K/Akt signaling following induction by insulin and IGF-1, exerts an influence on AD and PD physiopathology. 29515352 2018
Entrez Id: 3479
Gene Symbol: IGF1
IGF1
0.100 AlteredExpression disease BEFREE The imaging analysis proved a significant negative correlation (FDR corrected <i>P</i>-value = 0.013) between continuous levels of serum IGF-1 in patients with PD and the connectivity, but not integrity, in following fibers while controlling for age, sex, body mass index, depressive symptoms, education years, cognitive status and disease duration: middle cerebellar peduncle, cingulum, genu and splenium of the corpus callosum. 30450079 2018
Entrez Id: 3479
Gene Symbol: IGF1
IGF1
0.100 Biomarker disease BEFREE Furthermore, high serum IGF1 levels may be a potential diagnostic biomarker for PD in the Han Chinese population, although they do not correlate with a more severe motor dysfunction. 28221705 2017
Entrez Id: 3479
Gene Symbol: IGF1
IGF1
0.100 Biomarker disease BEFREE Follow-up studies are warranted to assess if IGF-1 is related to the development of dementia in PD. 29065116 2017
Entrez Id: 3479
Gene Symbol: IGF1
IGF1
0.100 AlteredExpression disease BEFREE Nevertheless, additional endeavors are required to further explore the association between serum IGF-1 levels and diagnosis, prognosis and early therapy for PD. 26657015 2015
Entrez Id: 3479
Gene Symbol: IGF1
IGF1
0.100 Biomarker disease BEFREE The results suggest that: 1) IGF-I, IGF-II, and neurotrophin signaling are more impaired in DLB than PD, corresponding with DLB's more pronounced neurodegeneration, oxidative stress, and alpha-synuclein accumulation; 2) MnCl2 exposure causes PD/DLB associated abnormalities in central nervous system neurons, and therefore may contribute to their molecular pathogenesis; and 3) molecular abnormalities in PD/DLB overlap with but are distinguishable from Alzheimer's disease. 19276553 2009
Entrez Id: 3479
Gene Symbol: IGF1
IGF1
0.100 Biomarker disease BEFREE These results suggest the therapeutic potential of IGF-1 pathway in Parkinson disease. 19470380 2009
Entrez Id: 3479
Gene Symbol: IGF1
IGF1
0.100 Biomarker disease BEFREE This suggests a dual role of IGF-1 to both increase hNPC survival after transplantation and exert trophic effects on degenerating dopamine neurons in this rat model of PD. 18061591 2008